Concepedia

Christopher P. Locher

CP

Statistics

Publications

25

Citations

1.3K

H-Index

20

Active since

1996

Affiliations

University of California, San Francisco(Current)

Vertex Pharmaceuticals (United States)

Texas Biomedical Research Institute

Maxygen (United States)

Harvard University

Christopher P. Locher is an author at University of California, San Francisco specializing in life sciences, infectious diseases, and immunology.

Publications per year

1996–2023

25

Publications

25

Novel Inhibitors of Cholesterol Degradation in Mycobacterium tuberculosis Reveal How the Bacterium’s Metabolism Is Constrained by the Intracellular Environment

Brian C. VanderVen, Ruth J. Fahey, Wonsik Lee et al. · PLoS Pathogens · 2015 · 274 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

Antiviral activity of Hawaiian medicinal plants against human immunodeficiency Virus Type-1 (HIV-1)

Christopher P. Locher, Myriam Witvrouw, Marie-Pierre de Béthune et al. · Phytomedicine · 1996 · 116 citations · Full text

Life Sciences, Botany, Infectious Diseases +16

Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria

Irina A. Rodionova, Brian M. Schuster, Kristine M. Guinn et al. · mBio · 2014 · 84 citations · Full text

Life Sciences, Biochemistry, Pharmacology +17

A modular vaccine platform enabled by decoration of bacterial outer membrane vesicles with biotinylated antigens

Kevin B. Weyant, Ayomide Oloyede, Sukumar Pal et al. · Nature Communications · 2023 · 82 citations · Full text

Pharmacy, Biotechnology, Immunology +17

A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections

Christopher P. Locher, Steven M. Jones, Brian L. Hanzelka et al. · Antimicrobial Agents and Chemotherapy · 2014 · 81 citations · Full text

Medicine, Infectious Diseases, Pharmacology +14

1–5 of 25